tiprankstipranks
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
US Market
CHGCF
Chugai Pharmaceutical Co
RESEARCH TOOLSreports
Want to see CHGCF full AI Analyst Report?

Chugai Pharmaceutical Co (CHGCF) Income Statement

22 Followers

Chugai Pharmaceutical Co Income Statement

Last quarter (Q1 2026), Chugai Pharmaceutical Co's total revenue was ¥321.75B, an increase of 11.54% from the same quarter last year. In Q1, Chugai Pharmaceutical Co's net income was ¥115.42B. See Chugai Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 1.26T¥ 1.17T¥ 1.11T¥ 1.26T¥ 999.76B
Gross Profit
¥ 894.25B¥ 830.75B¥ 693.01B¥ 783.06B¥ 660.27B
Operating Expenses
¥ 304.06B¥ 286.84B¥ 277.34B¥ 249.12B¥ 226.53B
Depreciation and Amortization
¥ 32.53B¥ 31.66B¥ 31.74B¥ 31.43B¥ 30.87B
EBITDA
¥ 631.37B¥ 574.80B¥ 475.64B¥ 562.66B¥ 450.30B
Operating Income
¥ 590.19B¥ 543.91B¥ 415.67B¥ 533.94B¥ 433.74B
Other Income/Expenses
¥ 7.62B¥ -873.00M¥ 28.16B¥ -2.78B¥ -14.35B
Pretax Income
¥ 597.81B¥ 543.03B¥ 443.82B¥ 531.17B¥ 419.38B
Net Income
¥ 434.01B¥ 387.32B¥ 325.47B¥ 374.43B¥ 303.00B
Per Share Metrics
Basic EPS
¥ 263.73¥ 235.39¥ 197.83¥ 227.64¥ 184.29
Diluted EPS
¥ 263.72¥ 235.36¥ 197.80¥ 227.57¥ 184.17
Weighted Average Shares Outstanding
 1.65B 1.65B 1.65B 1.64B 1.64B
Weighted Average Shares Outstanding (Diluted)
 1.65B 1.65B 1.65B 1.65B 1.65B
Currency in JPY

Chugai Pharmaceutical Co Earnings and Revenue History